Results 351 to 360 of about 1,792,624 (390)

Advances in Tumor Antigen Vaccines: A New Frontier in Cancer Immunotherapy. [PDF]

open access: yesInt J Med Sci
Feng W   +7 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Developing Covid-19 Vaccines at Pandemic Speed.

New England Journal of Medicine, 2020
Developing Covid-19 Vaccines at Pandemic Speed An ideal vaccine platform would support development from viral sequencing to clinical trials in less than 16 weeks, demonstrate elicitation of consist...
N. Lurie   +3 more
semanticscholar   +1 more source

COVID-19 vaccines

Current Opinion in Immunology, 2021
COVID-19 is a pandemic of unprecedented proportions in recent human history. Less than 18 months since the onset of the pandemic, there are close to two hundred million confirmed cases and four million deaths worldwide.
D. Ndwandwe, C. Wiysonge
semanticscholar   +1 more source

Vaccines, vaccination in Brucellosis

Annales de l'Institut Pasteur / Microbiologie, 1987
International ...
Plommet, Michel   +2 more
openaire   +3 more sources

Footrot vaccines and vaccination

Vaccine, 2014
Research on footrot in small ruminants, which is caused by Dichelobacter nodosus, has led to development of vaccines and their application for control, treatment and eradication of the disease in sheep. Footrot vaccines have evolved over decades to contain monovalent whole cell, multivalent recombinant fimbrial, and finally mono or bivalent recombinant
Om, Dhungyel   +2 more
openaire   +2 more sources

Vaccines and Vaccination

New England Journal of Medicine, 2001
More than 70 bacteria, viruses, parasites, and fungi are serious human pathogens.1 Vaccines are available against some of these agents and are being developed against almost all the other bacteria and viruses and about half of the parasites. Table 1 lists infections for which there are now licensed vaccines and those for which a candidate vaccine has ...
openaire   +2 more sources

SARS-CoV-2 Vaccines.

Journal of the American Medical Association (JAMA), 2021
Shortly after SARS-CoV emerged at the turn of the 21st century, the spike (S) protein (particularly in its prefusion [native] conformation) was identified as the immunodominant antigen of the virus.1 Evaluation of patients with SARS-CoV-2 revealed that ...
C. Creech   +2 more
semanticscholar   +1 more source

Vaccines

Current Opinion in Immunology, 1990
Much progress has been made towards reaching an understanding of immune responses at the molecular level. This has provided much needed information for identifying the antigens which will afford protection against diseases such as rabies, malaria, whooping cough, hepatitis and acquired immune deficiency syndrome, and for presenting them to the immune ...
openaire   +3 more sources

Vaccines

European Journal of Gastroenterology & Hepatology, 1999
Extensive research with mice has shown that animals can be protected from or cured of Helicobacter infection by immunization. A therapeutic effect has also been demonstrated in ferrets. The possibility of developing a vaccine against H. pylori-associated diseases that will work in humans has been the stimulus for intense research activity.
openaire   +2 more sources

Home - About - Disclaimer - Privacy